Dare Bioscience (DARE) Assets (2013 - 2026)
Dare Bioscience's (DARE) quarterly Assets came in at $32.5 million in Q4 2025, up 46.94% YoY from $22.1 million in Q4 2024, and up 5.61% on a QoQ basis from $30.7 million in Q3 2025.
Dare Bioscience (DARE) Assets (2013 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 13 years of Assets data on file, last reported at $32.5 million in Q4 2025.
- Quarterly Assets rose 46.94% year-over-year to $32.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32.5 million (up 46.94% YoY) and the FY2025 annual result came in at $32.5 million, up 46.94% from the prior year.
- Assets improved to $32.5 million in Q4 2025, from $30.7 million in the prior quarter.
- In the past five years, Assets ranged from a high of $55.8 million in Q4 2021 to a low of $10.5 million in Q1 2021.
- A 5-year average of $29.8 million and a median of $24.3 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2021 — Assets jumped 639.1% — and 2024, when it plunged 57.15%.
- Tracing DARE's Assets over 5 years: stood at $55.8 million in 2021, then decreased by 21.47% to $43.8 million in 2022, then tumbled by 51.44% to $21.3 million in 2023, then advanced by 3.85% to $22.1 million in 2024, then surged by 46.94% to $32.5 million in 2025.
- The last three Assets figures came in at $32.5 million (Q4 2025), $30.7 million (Q3 2025), and $13.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | 2.10 Bn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | 25.60 Bn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 19.82 Bn |
| 10 | Dare Bioscience | 12.21 Mn | -406,442.64 | -132,343.00 | 22.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.37 Mn |
| Dec 31, 2025 | 32.47 Mn |
| Sep 30, 2025 | 30.75 Mn |
| Jun 30, 2025 | 12.98 Mn |
| Mar 31, 2025 | 18.62 Mn |
| Dec 31, 2024 | 22.10 Mn |
| Sep 30, 2024 | 18.06 Mn |
| Jun 30, 2024 | 23.61 Mn |
| Mar 31, 2024 | 13.01 Mn |
| Dec 31, 2023 | 21.28 Mn |
| Sep 30, 2023 | 25.05 Mn |
| Jun 30, 2023 | 23.21 Mn |
| Mar 31, 2023 | 30.37 Mn |
| Dec 31, 2022 | 43.83 Mn |
| Sep 30, 2022 | 50.38 Mn |
| Jun 30, 2022 | 51.39 Mn |
| Mar 31, 2022 | 49.19 Mn |
| Dec 31, 2021 | 55.81 Mn |
| Sep 30, 2021 | 48.81 Mn |
| Jun 30, 2021 | 14.82 Mn |